The present invention relates to a novel naphtho class of compounds as Stat3 pathway inhibitors and as cancer stem cell inhibitors; to methods of using such compounds to treat cancer; to methods of using such compounds to treat disorders in a mammal related to aberrant Stat3 pathway activity; to pharmaceutical compositions containing such compounds.
本发明涉及一种新型的
萘类化合物,作为Stat3通路
抑制剂和癌症干细胞
抑制剂;使用这些化合物治疗癌症的方法;使用这些化合物治疗哺乳动物中与异常Stat3通路活性相关的疾病的方法;以及含有这些化合物的制药组合物。